002873.SZ
Guiyang Xintian Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 8.39
−0.59%Year over year
Reported trailing growth
- Revenue
- -15.8%
- EBITDA
- —
- EBIT
- -78.8%
- EPS
- -80.9%
- Free cash flow
- +112.2%
- Operating cash flow
- +33.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -11.7%
- EBITDA
- -30.4%
- EBIT
- -56.4%
- Net income
- -56.6%
- EPS
- -56.8%
- Free cash flow
- +20.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026